References SURMOUNT-5 head-to-head trial (NEJM, May 2025) summary via American College of Cardiology: SURPASS-2 primary publication (NEJM, 2021): Eli Lilly SURMOUNT-1 results announcement (NEJM data): Insights into the Mechanism of Action of Tirzepatide (PMC narrative review): Tirzepatide is an imbalanced and biased dual GIP/GLP-1 receptor agonist (PMC): SURMOUNT-5 GI tolerability / discontinuation data (Applied Clinical Trials, tctmd, DiabetesontheNet coverage): SURMOUNT-1 to -4 GI tolerability (Rubino 2025, Diabetes Obesity & Metabolism): Community sentiment context Reddit GLP-1 side-effect analysis and comparative meta-analyses (PMC): Research Use Only Notice: The content on this page is provided for informational and educational purposes only
Exosomes are tiny, nano-sized vesicles - about 30 to 150 nanometers in size - released by nearly all types of cells, including stem cells
GLP-1 supplements for GI Side Effects Our supplements, Probiotic Plus and BPC-157*, are specially formulated to support patients experiencing gastrointestinal (GI) side effects from GLP-1 medications
While not universally experienced, this thermogenic shift reflects real changes in how your body regulates temperature during weight loss therapy
Can bacteriostatic water be used for single-use applications
